Automation Upgrade at Influenza Vaccine Manufacturing Facility

This retrofit and phased expansion of an existing biotechnology facility aimed to reduce costs by increasing efficiency, increasing yield, reducing waste and increasing process automation – including multiple interfaces with manufacturing.


  • Liverpool, North West England, UK


  • MedImmune

Project Value

  • 35 million CAD (£20 M)

Project Status

  • Completed


  • ISPE 2013 Facility of the Year Award for Equipment Innovation
Increase in yield
15% 15%
Reduction in seasonal labour
25% 25%
Decrease in reject rate
8% 8%